Recombinant Anti-SNCA VHH Single Domain Antibody (PNBL-086) (CAT#: PNBL-086)

• Remarkable Sensitivity
  We used the anti-SNCA antibody in our Western Blot assays and were thoroughly impressed. The antibody's ability to detect even the minute amounts of alpha-synuclein highlights its remarkable sensitivity. The results we obtained were clear and highly reproducible, contributing positively to our ongoing research in alpha-synuclein-related pathologies.
• Enhances Experimental Outcomes
  We integrated this antibody into our protein structural studies, and it has greatly facilitated our understanding of SNCA conformational dynamics. The stability of the antibody ensures that our experiments yield reliable and significant outcomes, providing valuable insights into potential therapeutic interventions for synucleinopathies.
• Reliable Research Partner
  I've been using the Anti-SNCA Single Domain Antibody for functional studies related to Parkinson's disease, and it has proven to be highly reliable. Its sensitivity and specificity are unmatched, providing consistent results that enhance the credibility of our research findings. The antibody's stability during experiments is remarkable, and its animal-free production aligns with ethical research standards, making it an essential tool in our lab.

1. Q 1: What protein target does this antibody bind to, and why is this important?

   A: The antibody specifically binds to SNCA, also known as alpha-synuclein. This is important because misfolded SNCA is involved in several neurological diseases, including Parkinson's and Alzheimer's, offering insights into therapeutic intervention points and pathology.

2. Q 2: What applications can be performed using the Anti-SNCA Single Domain Antibody?

   A: This antibody is ideal for applications like Western Blot and functional studies due to its high specificity and sensitivity. It allows researchers to detect and analyze proteins involved in various pathways and interactions within cells, crucial for understanding cellular mechanisms and disease processes.

3. Q 3: How does the Anti-SNCA Antibody contribute to Parkinson's disease research?

   A: The antibody targets alpha-synuclein (SNCA), a protein crucially implicated in Parkinson's disease. Abnormal aggregation of SNCA is a hallmark of neurodegenerative disorders. This antibody helps study these aggregates, aiding in the understanding of disease mechanisms and the development of therapeutic strategies.

View the frequently asked questions answered by Creative Biolabs Support.